Design and Synthesis of New N1 and C3-Substituted 4-Fluoroindolic Melatoninergics

Author(s): Andrew Tsotinis, Andreas Eleutheriades, Kathryn Davidson, David Sugden, Andrew Tsotinis, Andreas Eleutheriades, Kathryn Davidson, David Sugden

Journal Name: Current Drug Discovery Technologies

Volume 4 , Issue 3 , 2007

Become EABM
Become Reviewer
Call for Editor


A series of new C-3 and N1-substituted 4-fluorotryptamides have been prepared and tested for their ability to activate pigment granule aggregation in Xenopus laevis melanophores and bind to the recombinant human MT1 and MT2 melatonin receptor subtypes expressed in NIH 3T3 cells. Planar sp2 geometry at C-3-βC seems to decrease the population of the preferred conformation as it renders 4-fluoroindoles 4b-d weaker antagonists than their C-3-βC-unsubstituted congeners 3a-e. This effect is not preclusively linked with the C-3 region, as the same geometry around N1 (compounds 5a-c) similarly leads to weak antagonistic action. Last, the new C-3 substituted 4-fluorotryptamides presented herein are substantially more potent than their respective N-OMe functionalized congeners, previously reported.

Keywords: Substituted 4-fluoroindoles, synthesis, melatoninergic activity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [198 - 207]
Pages: 10
DOI: 10.2174/157016307782109715
Price: $65

Article Metrics

PDF: 13